Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study-Reference-Cited by-同舟云学术

Melatonin reduces lung oxidative stress in patients with chronic obstructive pulmonary disease: a randomized, double-blind, placebo-controlled study

Published:2012-04-17 Issue:3 Volume:53 Page:238-244
ISSN:0742-3098
Container-title:Journal of Pineal Research
language:en
Short-container-title:

Author:

de Matos Cavalcante Antonio George,de Bruin Pedro Felipe Carvalhedo,de Bruin Veralice Meireles Sales,Nunes Deuzilane Muniz,Pereira Eanes Delgado Barros,Cavalcante Marina Medeiros,Andrade Geanne Matos

Publisher

Wiley

Subject

Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-079X.2012.00992.x/fullpdf

Reference55 articles.

1. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper;Celli;Eur Respir J,2004

2. New insights into the immunology of chronic obstructive pulmonary disease;Brusselle;Lancet,2011

3. Systemic manifestations and comorbidities of COPD;Barnes;Eur Respir J,2009

4. Oxidative stress in expired breath condensate of patients with COPD;Kostikas;Chest,2003

5. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis;Gan;Thorax,2004

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plant-based therapeutics for chronic obstructive pulmonary diseases: Nanoformulation strategies to overcome delivery challenges;Food Bioscience;2024-04

2. Melatonin is a potential novel analgesic agent for osteoarthritis: Evidence from cohort studies in humans and preclinical research in rats;Journal of Pineal Research;2024-02-13

3. Multiomics was used to clarify the mechanism by which air pollutants affect chronic obstructive pulmonary disease: A human cohort study;Toxicology;2024-01

4. Melatonin supplementation enhances pulmonary rehabilitation outcomes in COPD: a randomized, double-blind, placebo-controlled study;Respiratory Medicine;2023-12

5. Targeting accelerated pulmonary ageing to treat chronic obstructive pulmonary disease‐induced neuropathological comorbidities;British Journal of Pharmacology;2023-11-15